MBX Biosciences Announces Positive Phase 1 Multiple Ascending Dose Data for MBX 2109, a Long-Acting Parathyroid Hormone Peptide Prodrug, in Healthy Adults
September 11, 2023
September 11, 2023
August 7, 2023
July 10, 2023
November 14, 2022
October 5, 2022
September 10, 2019